Mosel Pearlman-Ramirez v. HHS - Tdap, Guillain-Barré Syndrome (GBS) (2023)

Mosel Pearlman-Ramirez filed a petition for compensation on June 9, 2022, alleging that the Tdap vaccine received on April 19, 2021, caused Guillain-Barré Syndrome (GBS) and residual effects lasting more than six months. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused the alleged injury.

Despite this denial, the parties reached a stipulation for award, agreeing that Mosel Pearlman-Ramirez should receive compensation. The court adopted the stipulation, awarding a lump sum of $110,000.00 to cover all damages.

This decision was entered on May 8, 2023, following the parties' agreement to expedite judgment. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses.

Petitioner counsel was Elizabeth Abramson of Maglio Christopher & Toale, P.A., and respondent counsel was Voris Johnson of the United States Department of Justice. Special Master Herbrina Sanders issued the decision.